Skip to content
sellModerate cluster of 510b5-1 plan

Mark S Schroeder sold $1.3M of LH

EVP, Pres Diagnostics & COO at LABCORP HOLDINGS INC.. 5,339 shares at an average of $249.23, traded Feb 28, 2025, filed Mar 4, 2025.

Warning score
45
Value
$1.3M
5,339 shares
Holdings after
4,960
-52% from before
From 52-week low
+19%
low $207.55, close $247.16
From 52-week high
-0%
high $248.25, as of Feb 28, 2025

Score components

  • Role
    COO
    +20
  • Trade size
    $1.3M at market
    +25
  • Share of holdings sold
    Sold 52% of holdings
    +20
  • Cluster
    5 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

LHOct 9, 2026 · close 312.15
Since filing Mar 4, 2025: +23.5%SPY +37.6% · excess -14.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001127602-25-007615, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Feb 28, 2025MOption exercise
Common Stock10b5-1
+3,903$131.43$513k10,299Mar 4, 2025
Feb 28, 2025SOpen-market sale
Common Stock10b5-1
-5,339$249.23$1.3M4,960Mar 4, 2025
Feb 28, 2025MOption exercise
Non-qualified Stock Optionsderivative10b5-1
-3,903$0.00$00Mar 4, 2025

Related signals

Other insiders at LABCORP HOLDINGS INC. and this insider’s other filings.

ScoreSideCompanyInsiderValueSharesFiled
38Weaksell 210b5-1LH
LABCORP HOLDINGS INC.
Mark S Schroeder
EVP, Pres Diagnostics & COO
$610k2,635
20Weaksell 210b5-1LH
LABCORP HOLDINGS INC.
Amy B. Summy
EVP, Chief Marketing Officer
$176k758
41Moderatesell 4LH
LABCORP HOLDINGS INC.
Kerrii B Anderson
director
$128k500
55Moderatesell 6LH
LABCORP HOLDINGS INC.
Sandra D van der Vaart
EVP, Chief Legal Officer
$330k1,314
17Weaksell 610b5-1LH
LABCORP HOLDINGS INC.
Amy B. Summy
EVP, Chief Marketing Officer
$57k226
40Moderatesell 5LH
LABCORP HOLDINGS INC.
Peter J Wilkinson
SVP, Chief Accounting Officer
$348k1,413
30Weaksell 410b5-1LH
LABCORP HOLDINGS INC.
Adam H Schechter
President & CEO
$1.5M6,121
8Weaksell10b5-1LH
LABCORP HOLDINGS INC.
Kerrii B Anderson
director
$235k1,000
50Moderatesell 4LH
LABCORP HOLDINGS INC.
Glenn A Eisenberg
Executive Vice President
$2.8M11,711
48Moderatesell 4LH
LABCORP HOLDINGS INC.
Dwight Gary Gilliland
director
$241k1,000

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Mark S Schroeder sold $1.3M of LH | InsiderTell